Jeffrey Schwartz - May 20, 2021 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Director, 10%+ Owner
Signature: /s/ Jeffrey Schwartz
Stock symbol: SWTX
Transactions as of: May 20, 2021
Transactions value $: $0
Form type: 4
Date filed: 5/24/2021, 05:45 PM
Next filing: Jul 16, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Award	$0	+1.11K		$0.00	1.11K	May 20, 2021	Direct	F1
holding	SWTX	Common Stock						5.83M	May 20, 2021	See Footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWTX	Stock Option (Right to Buy)	Award	$0	+7K		$0.00	7K	May 20, 2021	Common Stock	7K	$75.94	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock award. The restricted stock award will vest in full on the earlier of (1) May 20, 2022 and (2) the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.
F2	The options will vest in full on the earlier of (1) May 20, 2022 and (2) the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.
F3	Represents shares of common stock held directly by BC SW, LP. Bain Capital Life Sciences Investors, LLC ("BCLSI") is the general partner of BC SW, LP. Mr. Schwartz is a manager of BCLSI. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the shares of common stock held by BC SW, LP. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.